Dare Bioscience Inc. Revenue 2012–2025
Dare Bioscience Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Dare Bioscience Inc. revenue for the quarter ending March 31, 2026 was 152455, a 499.58% increase year-over-year.
- Dare Bioscience Inc. revenue for the twelve months ending March 31, 2026 was 221835, a 78.50% decrease year-over-year.
- Dare Bioscience Inc. annual revenue for 2025 was 1.0 M, a 10429.36% increase from 2024.
- Dare Bioscience Inc. annual revenue for 2024 was 9784, a 99.65% decrease from 2023.
- Dare Bioscience Inc. annual revenue for 2023 was 2.8 M, a 71.92% decrease from 2022.
- Dare Bioscience Inc. annual revenue for 2022 was 10.0 M.
Dare Bioscience Inc. (DARE) — Frequently Asked Questions
Dare Bioscience Inc. (DARE) is a publicly traded US company. It has a market capitalization of $23M. In fiscal 2025 it reported revenue of $1M and net income of -$13M. Explore DARE's stock price, financial statements, earnings history, margins and key ratios below.
What is Dare Bioscience Inc.'s market cap?
Dare Bioscience Inc. (DARE) has a market capitalization of $23M.
What is the DARE stock price?
DARE trades at $2.02 (+0.75% on the day).
How much revenue does Dare Bioscience Inc. make?
Dare Bioscience Inc. reported revenue of $1M in fiscal 2025.
Is DARE profitable?
In fiscal 2025, Dare Bioscience Inc. reported net income of -$13M.